$5.80
0.173.02%
Pre-Market: 9:02 AM EDT
Comments
Loading...
Xeris Biopharma Holdings Stock Guidance | NASDAQ:XERS | Benzinga
Xeris Biopharma Holdings issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | XERS | Xeris Biopharma Holdings | FY | 2025 | — | — | — | $255.00M | $275.00M | $239.77M | Get Alert |
| 01/10/2025 | XERS | Xeris Biopharma Holdings | Q4 | 2024 | — | — | — | $60.00M | $60.00M | $56.74M | Get Alert |
| 01/10/2025 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $203.00M | $203.00M | $199.70M | Get Alert |
| 11/08/2024 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $198.00M | $202.00M | $193.40M | Get Alert |
| 08/08/2024 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $190.00M | $200.00M | $187.35M | Get Alert |
| 07/08/2024 | XERS | Xeris Biopharma Holdings | Q2 | 2024 | — | — | — | $47.00M | — | $44.89M | Get Alert |
| 05/09/2024 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $175.00M | $200.00M | $184.43M | Get Alert |
| 03/06/2024 | XERS | Xeris Biopharma Holdings | FY | 2024 | — | — | — | $170.00M | $200.00M | $188.01M | Get Alert |
| 01/04/2024 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $165.00M | $165.00M | $161.96M | Get Alert |
| 11/09/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $160.00M | $165.00M | $158.23M | Get Alert |
| 10/16/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $155.00M | $165.00M | $158.23M | Get Alert |
| 08/08/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $145.00M | $165.00M | $149.35M | Get Alert |
| 05/09/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $135.00M | $165.00M | $146.90M | Get Alert |
| 03/08/2023 | XERS | Xeris Biopharma Holdings | FY | 2023 | — | — | — | $135.00M | $165.00M | $152.31M | Get Alert |
FAQ
What is the most recent guidance for Xeris Biopharma Holdings (XERS)?
There have been no specific sales or earnings guidance reported for Xeris Biopharma Holdings in recent months.
Browse guidance and forecast on all stocks.